Latest Breaking News On - Stijn van rompay - Page 3 : comparemela.com

Pleco Therapeutics B V : Pleco Therapeutics receives FDA Orphan Drug Designation

Pleco Therapeutics B V : Pleco Therapeutics receives FDA Orphan Drug Designation
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesStijn van rompayJulie powellHelen popeIvo timmermansHyloris pharmaceuticalsPleco therapeutics united states incDrug administrationHyloris pharmaceuticals sa euronext brusselsOrphan drug designationPleco therapeuticsAcute myeloid leukaemiaDrug designationChief executive officerEuronext brussels

Pleco Therapeutics receives FDA Orphan Drug Designation

The U.S Food and Drug Administration (FDA) has granted Orphan Drug Designation to Pleco Therapeutics BV’s lead compound, PTX-252 for the treatment of AML..

New yorkUnited statesJulie powellHelen popeIvo timmermansStijn van rompayHyloris pharmaceuticals sa euronext brusselsHyloris pharmaceuticalsDrug administrationPleco therapeutics united states incOrphan drug designationPleco therapeuticsAcute myeloid leukaemiaDrug designationChief executive officerEuronext brussels

Pleco Therapeutics receives FDA Orphan Drug Designation

Pleco Therapeutics receives FDA Orphan Drug Designation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesIvo timmermansJulie powellHelen popeStijn van rompayHyloris pharmaceuticalsPleco therapeutics united states incDrug administrationHyloris pharmaceuticals sa euronext brusselsOrphan drug designationPleco therapeuticsAcute myeloid leukaemiaDrug designationChief executive officerEuronext brussels

Orphan Drug Designation Granted to PTX-252 by U S FDA for the Treatment of Acute Myeloid Leukaemia (AML)

Orphan Drug Designation Granted to PTX-252 by U S FDA for the Treatment of Acute Myeloid Leukaemia (AML)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesStijn van rompayIvo timmermansJean luc vandebroekLeukemia lymphoma societyPleco therapeutics united states incHyloris pharmaceuticalsDrug administrationHyloris pharmaceuticals sa euronext brusselsOrphan drug designation grantedAcute myeloid leukaemiaEuronext brusselsOrphan drug designationPleco therapeuticsVan rompay

Orphan Drug Designation Granted to PTX-252 by U S FDA for the Treatment of Acute Myeloid Leukaemia (AML)

Orphan Drug Designation Granted to PTX-252 by U S FDA for the Treatment of Acute Myeloid Leukaemia (AML)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJean luc vandebroekIvo timmermansStijn van rompayHyloris pharmaceuticalsDrug administrationLeukemia lymphoma societyPleco therapeutics united states incHyloris pharmaceuticals sa euronext brusselsDrug designation grantedAcute myeloid leukaemiaEuronext brusselsOrphan drug designationPleco therapeuticsVan rompay